The above in vivo results revealed the protective efficiency of KDM3A knock-out against hyperglycemia-induced persistent myocardial injury and cardiac dysfunction might be associated with the inhibition of the expression and transcriptional activity of NF-κB/P65. This evidence concerns the gene NFKB1 and Hyperglycemia.